GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Biomarker Identification to Increase Adjunctive Cryoablation and Checkpoint-Inhibitor Immunotherapy Response

$269,684
Eric Wehrenberg-Klee · Massachusetts General Hospital · K08 · FY2021 · CA

Biomarker Identification to Increase Adjunctive Cryoablation and Checkpoint-Inhibitor Immunotherapy Response

$269,684
Eric Wehrenberg-Klee · Massachusetts General Hospital · K08 · FY2022 · CA

METABOLIC DEMANDS AND DETERMINANTS IN THE RCC TUMOR MICROENVIRONMENT

$269,665
Vanderbilt University Medical Center · · FY2022 · Defense Health Agency

Leveraging doxorubicin immune-modulation, blood-brain barrier opening, and personalized medicine for effective immunotherapy in glioblastoma. A mechanistic approach and pharmacokinetic trial.

$269,642
Adam M Sonabend · University Of California, San Francisco · U19 · FY2025 · CA

Project 3 - Mitochondrial regulation of the immunosuppressive prostate cancer microenvironment

$269,629
Dmitry Isaac Gabrilovich · Wistar Institute · P01 · FY2018 · CA

Neutrophil-Mediated Melanoma Cell Adhesion and Migration

$269,582
Cheng Dong · Pennsylvania State University, The · R01 · FY2006 · CA

Clinical Investigation and Precision Therapy

$269,566
Shridar Ganesan · Rutgers Biomedical And Health Sciences · P30 · FY2025 · CA

Molecular Regulation of Folate and Antifolate Transport

$269,500
Larry H. Matherly · Wayne State University · R01 · FY2017 · CA

Targeting macrophages to reduce the combined injury effects of radiation and virus exposure

$269,500
Brian Marples · University Of Rochester · R21 · FY2022 · AI

Molecular Regulation of Folate and Antifolate Transport

$269,500
Larry H. Matherly · Wayne State University · R01 · FY2018 · CA

Gangliosides and the Biology of Human Neuroblastoma

$269,489
Stephan Ladisch · Children'S Research Institute · R01 · FY2006 · CA

Innate Factors in Tumor Antigen Cross-Presentation

$269,433
Thomas F Gajewski · University Of Chicago · P01 · FY2012 · CA

Targeting cellular senescense in pancreatic cancer

$269,280
Haiyong Han · Translational Genomics Research Inst · R21 · FY2025 · CA

Immune Regulation of Gastric Cancer

$269,225
Jonathan Busada · West Virginia University · P20 · FY2021 · GM

THE ROLE AND MECHANISMS OF CD4+ T CELLS IN ANTITUMOR IMMUNITY

$269,219
Rongfu Wang · Baylor College Of Medicine · P01 · FY2011 · CA

Role of elF2a phosphorylation and ER stress in hypoxia tolerance and tumor growth

$269,215
Constantinos Koumenis · University Of Pennsylvania · R01 · FY2007 · CA

VSV INFECTION OF THE CENTRAL NERVOUS SYSTEM

$269,168
New York University · R01 · FY2005 · DC

Defining the role of KEAP/NRF2 signaling dysregulation and sensory nerve reprograming during acquisition of cisplatin resistance and metastasis in HNSCC

$269,157
Abdullah Ali Osman · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA

An Orthotopic Murine Model of HCC: Immunotolerance and Prevention

$269,129
Kevin Finnbar Staveleyo'carroll · Medical University Of South Carolina · R01 · FY2014 · CA

CHIMERIC T CELLS TARGETING NEUROBLASTOMA

$269,122
Malcolm K Brenner · Baylor College Of Medicine · P01 · FY2011 · CA

FAK and Pky2 in Determination of Glioblstoma Phenotype

$269,087
Joseph C Loftus · Mayo Clinic Arizona · R01 · FY2006 · CA

Immune Regulation of Gastric Cancer

$269,082
Jonathan Busada · West Virginia University · P20 · FY2022 · GM

Core 1: Systems Pathology Core

$269,026
Anil V Parwani · Cedars-Sinai Medical Center · P01 · FY2025 · CA

Core 1: Systems Pathology Core

$269,026
Anil V Parwani · Cedars-Sinai Medical Center · P01 · FY2023 · CA

Nanoformulations for siRNA Delivery to Ovarian Cancer

$269,012
Phillip A Sharp · Massachusetts Institute Of Technology · U54 · FY2010 · CA